InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.00
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.24
(
0.03%
)
Bitcoin
62,568.30
(
-0.53%
)
Post# of 11554
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

StocksDiva

Send PM Follow Ignore
Followers 378
Posts 20728
Boards Moderated 2
Alias Born 03/28/2010

StocksDiva

Re: StocksDiva post# 11455

Tuesday, 05/27/2014 8:44:17 AM

Tuesday, May 27, 2014 8:44:17 AM

Post# of 11554
NBS Neostem announces grant of two U.S. patents for CD34 cell program (NBS) :

Co announced the expansion of intellectual property protection surrounding its CD34 Cell Program. That program is developing therapeutics to address ischemia, the process that occurs when the supply of oxygenated blood in the body is restricted.
The recently granted U.S. patents relate to AMR-001, the Company's most clinically advanced product candidate in its CD34 Cell Program, which is designed to treat damaged heart muscle following acute myocardial infarction.


StocksDiva Bio Bin board

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up